Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Prostate Tumors Equipment Supplied In Europe
39 equipment items found
Manufactured by:biolitec AG based inWien, AUSTRIA
biolitec offers an extensive product range for urologic laser applications – state-of-the-art laser systems, fibers, handpieces, and other accessories. Thus you will be well equipped for the advanced treatment of BPH, bladder tumors, prostate tumors, partial kidney resection, condylomas, stricture, etc. ...
Manufactured by:LAVA Therapeutics N.V. based inUtrecht, NETHERLANDS
LAVA-1207, a gamma-delta bsTCE targeting the prostate specific membrane antigen (PSMA), has also demonstrated preclinical proof-of-concept. We expect to initiate a Phase I/IIa trial in metastatic castration-resistant prostate cancer in the second half of ...
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate tissue-based test to predict non-evolutive localized prostate cancer (LPCa). ...
Manufactured by:Care Wise Medical Products Corporation based inHENFIELD, UNITED KINGDOM
Designed for Laparoscopic Applications such as Cervical, Prostate and Gastric Cancer. ...
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
FIRMAGON® (degarelix) is a treatment for men with advanced hormone-dependent prostate cancer. It has a novel mechanism of action that is different from traditional LHRH agonist therapy commonly used. Decreasing testosterone levels can cause the cancer cells to die, thus reducing the size of the tumour and delaying its growth. To date, FIRMAGON has been approved in 74 countries. ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
GONAPEPTYL / DECAPEPTYL* (triptorelin acetat) is a solution for injection containing 0.1 mg/1 ml of triptorelin acetate (per prefilled syringe). It is indicated for the down regulation of the pituitary before and during controlled ovarian hyperstimulation in assisted reproduction ...
Manufactured by:Fortress Diagnostics based inCo. Antrim, UNITED KINGDOM
Acid Phosphatase determination is widely used particularly for the prostatic enzyme where elevated levels can be used as an indication of prostate carcinoma status. Elevated levels of total acid phosphate where prostate pathology is not a contributing factor can be due to liver disease and disintegrating blood platelets or erythrocytes. Fortress Diagnostics manufactures Acid Phosphstase reagents ...
Manufactured by:ABX Advanced Biochemical Compounds GmbH based inRadeberg, GERMANY
Radelumin is an advanced radiopharmaceutical product designed for diagnostic imaging, particularly in the detection of prostate-specific membrane antigen (PSMA) in patients. The injectable solutions of Radelumin are available in concentrations of 1300 MBq/ml and 2000 MBq/ml, using [18F]PSMA-1007 as the active compound. It plays a critical role in enhancing the precision of PET scans by providing ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LOCAMETZ, after radiolabeling with gallium-68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy, with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. for ...
Manufactured by:EDAP TMS based inVaulx-en-Velin, FRANCE
Focal treatment strategy for Prostate Cancer (PCa) is playing a growing role in today's surgical practice. By combining the latest imaging and treatment technologies, Focal One® brings the answer to current requirements for ideal focal therapy: accurate and MR-fused imaging, non-invasive approach, precise and efficient therapeutic HIFU energy and treatment validation imaging with ...
Manufactured by:OraSure Technologies based inBethlehem, PENNSYLVANIA (USA)
Colli-Pee® Small Volumes tubes are compatible with high-throughput instruments and can streamline the pre-analytical process, shorten turnaround time, minimize errors as well as reduce costs. Collector tubes can be pre-filled with a preservative for different urinary analytes, improving transport and storage of urine at room ...
Manufactured by:Fortress Diagnostics based inCo. Antrim, UNITED KINGDOM
The Fortress Diagnostics Acid Phosphatase Fast Red Reagents kit is for the quantitative determination of Acid Phosphatase in Serum. Acid Phosphatase determination is widely used particularly for the prostatic enzyme where elevated levels can be used as an indication of prostate carcinoma status. Elevated levels of total acid phosphate where prostate pathology is not a contributing factor can be ...
Manufactured by:OraSure Technologies based inBethlehem, PENNSYLVANIA (USA)
Colli-Pee® 20 mL allows for standardized and volumetric urine collection of the first 20mL of urine flow. This has applications in infectious diseases and oncology. Collector tubes can be pre-filled with a preservative for different urinary analytes, improving transport and storage of urine at room ...
by:Exact Sciences UK, Ltd. based inLondon, UNITED KINGDOM
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a patient's ...
Manufactured by:OraSure Technologies based inBethlehem, PENNSYLVANIA (USA)
For detection and monitoring of cancers, as well as new biomarker development, a larger volume of urine can be required. Additionally, Colli-Pee® Large Volumes supports multi-omics research. Collector tubes can be pre-filled with a preservative for different urinary analytes, improving transport and storage of urine at room temperature. Currently, the Colli-Pee Large Volumes variant is ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
SCIB2 is the second cancer vaccine based on the ImmunoBody® technology and encodes a modified antibody engineered to express the cancer antigen NY-ESO-1. This is a well-characterised and validated cancer target, being overexpressed in several tumour types including synovial sarcomas, oesophageal, liver, gastric, prostate and lung ...
by:Debiopharm based inLausanne, SWITZERLAND
Triptorelin is a gonadotropin releasing hormone (GnRH) agonist; Triptorelin, the active substance of Decapeptyl/Trelstar/Pamorelin/Triptodur, is a GnRH agonist analogue. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Triptorelin decreases the serum testosterone to castrate levels (estradiol in females). Androgen deprivation stops the growth of ...
Manufactured by:Exact Imaging based inMarkham, ONTARIO (CANADA)
ExactVu micro-ultrasound system for targeted biopsies for prostate cancer. ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a histone protein, leading to the suppression of gene expression. Some cancers depend on an abnormal pattern of gene expression and re-direct EZH2 to genes ...